Sign in
TerminatedNo phase

ES-HIFU, Prospective Data Collection of Patients Treated With Partial Gland HIFU Ablation for Prostate Cancer

Key facts

Who runs it
EDAP TMS S.A.
Where
Spain5 sites in 1 countryChoose a country to see its sites
Trial code
Status
Terminated
People taking part
14 people enrolled
Started
20 Apr 2023
Ended
14 Mar 2025
Type of study
Observational
Treatments tested
  • FocalOne
Record updated
2 April 2025
Why it stopped
The study was terminated early to integrate sites into a larger registry for a more comprehensive dataset, and not due to any safety concerns.

Who can take part

Age
18 years and older
Sex
Men only
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Patient eligible for HIFU treatment for prostate cancer, excluding whole gland treatment
  • Patient newly diagnosed with localized prostate cancer confirmed with an image guided biopsy (MRI and/or micro-ultrasounds)
  • Gleason ≤ 4+3
  • Patient scheduled for HIFU treatment as determined by the physician
  • Patient with healthcare coverage. Spanish-speaking patients with the ability to provide informed written consent

Who cannot take part

  • Patient with bilateral prostate cancer requiring whole gland treatment
  • Patient with an extension of cancer or seminal vesicle invasion
  • Patients clinically detected metastasis
  • Patient with contraindications for HIFU treatment: please refer to the complete Focal One user manual

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The objective of this study is to evaluate the clinical effectiveness and safety of treatment of prostate cancer in patients who have received a focal HIFU treatment using the Focal One medical device.

Treatments tested

  • FocalOne

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Multi-institutional Prospective Data Collection of Patients Treated With Partial Gland High-Intensity Focused Ultrasound (HIFU) Ablation for Prostate Cancer
Record updated
2 April 2025